Related Experiment Video
Updated: Oct 26, 2025

11:57
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
10.4K
Adapting Protocols or Models for Use in Insulin-Requiring Diabetes and Islet Transplant Recipients
Glenn M Ward1,2,3, Jacqueline M Walters1,3, Judith L Gooley1,3
1Department of Endocrinology and Diabetes, St. Vincent's Hospital, Fitzroy, VIC, Australia.
Frontiers in Endocrinology
|August 2, 2021
Summary
Researchers modified glucose challenge protocols and mathematical models to better estimate insulin secretion and sensitivity in patients with Type 1 diabetes (T1D) and T1D with impaired awareness of hypoglycemia, including islet transplant recipients.
Area of Science:
- Endocrinology
- Metabolic Research
- Diabetes Management
Background:
- Type 1 diabetes (T1D) and Type 2 diabetes (T2D) require precise monitoring of glucose metabolism.
- Impaired awareness of hypoglycemia is a significant complication in T1D, necessitating advanced assessment methods.
- Pancreatic islet transplantation is a treatment for T1D, but understanding post-transplant metabolic function is crucial.
Purpose of the Study:
- To describe modifications to glucose challenge protocols and mathematical models for estimating key metabolic parameters.
- To adapt these methods for patients with insulin-requiring diabetes (both T1D and T2D) and islet transplant recipients.
- To elucidate islet pathophysiology in islet transplant recipients through ongoing application of adapted protocols.
Main Methods:
- Clinical adaptation of glucose challenge protocols.
- Modification of mathematical models for assessing insulin secretion, insulin sensitivity, and glucose effectiveness.
- Application of evolved protocols and models across different diabetes patient groups.
Main Results:
- Developed and refined protocols and models tailored for T1D and T2D patients.
- Successfully applied adapted methods to islet transplant recipients.
- Demonstrated the utility of these adaptations in clarifying islet pathophysiology.
Conclusions:
- Modified protocols and models enhance the estimation of glucose-regulating parameters in complex diabetes populations.
- These adaptations are vital for managing T1D, T2D, and post-islet transplant patients.
- Ongoing research using these methods provides deeper insights into islet function and dysfunction.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
329
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
329
Insulin: Biosynthesis, Chemistry, and Preparation
700
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
700

